Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
| Image |  |
|---|---|
| Description | scientific article published on 27 March 2017 |
| Author/s |
author: David E. Gerber Muhammad S Beg |
| Publication date | March 27, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |